TREX1 and neoplasm: By controlling the amount of IFN-stimulatory DNA present in cancer cells, Trex1 is likely to reduce also IFNβ production by DCs activated by tumour-derived DNA, precluding spontaneous and radiation-induced T cell activation in immunogenic tumours infiltrated by sufficient numbers of DCs21, 22.